🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are urged to message these profiles privately for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is worrisome and could result in users administering products of unknown origin.

Some experts stated the popularity for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the service has taken down problematic material and prohibited associated keywords and search suggestions. The organization said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at home.

After minutes of entering one community, a vendor shared contact information, where the majority of purchases take place. The seller sent an guidebook and promised delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, health issues or past usage.

Item Information and Pricing

Inside these groups, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how long a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has already seen individuals harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to possibly significant health risks”.